Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House committee approves bill limiting some medical transition treatments for minors after contentious debate
Summary
The House Committee on Health and Human Services and Elderly Affairs advanced HB 377, which restricts certain puberty-blocking and cross-sex hormone treatments for minors, after votes on competing amendments and extended debate about parental rights, medical practice and patient safety.
The House Committee on Health and Human Services and Elderly Affairs voted to advance HB 377 as amended, a bill that would restrict access to certain puberty‑blocking and cross‑sex hormone treatments for minors. The committee adopted an amendment that provides a transition period for minors already on such treatments, but rejected an amendment that would have exempted more existing cases.
Committee members debated the bill for more than an hour, with supporters saying it protects children from long‑term medical decisions they may later regret and opponents saying it unduly intrudes on parents and the practice of medicine. Representative Mazur, sponsor of the bill, said the legislation is aimed at protecting minors and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
